UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 163 filers reported holding UNIQURE NV in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $209,078 | +22.2% | 30,883 | +21.1% | 0.04% | +8.1% |
| Q3 2023 | $171,065 | -31.0% | 25,494 | +17.8% | 0.04% | -26.0% |
| Q2 2023 | $248,040 | -37.3% | 21,644 | +10.2% | 0.05% | -56.1% |
| Q1 2023 | $395,731 | -20.9% | 19,649 | -11.0% | 0.11% | -76.5% |
| Q4 2022 | $500,259 | +18.3% | 22,067 | -2.1% | 0.48% | +25.0% |
| Q3 2022 | $423,000 | -4.3% | 22,535 | -5.0% | 0.39% | +15.5% |
| Q2 2022 | $442,000 | -10.7% | 23,730 | -13.4% | 0.34% | +44.2% |
| Q1 2022 | $495,000 | -25.6% | 27,388 | -14.5% | 0.23% | -3.7% |
| Q4 2021 | $665,000 | – | 32,041 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |